Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-23 Purchase |
2024-12-26 4:15 pm |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner |
10,101,010 | $0.99 | $10,000,000 | 20,121,828 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director 10% Owner |
38,236 | $0 | 38,236 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | SHAH BIMAL R. Director |
31,618 | $0 | 31,618 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer |
115,037 | $0 | 115,037 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director |
29,964 | $0 | 29,964 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Cunningham Richard Anthony Chief Executive Officer |
316,352 | $0 | 316,352 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director |
29,964 | $0 | 29,964 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. Director 10% Owner |
27,647 | $0 | 27,647 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Calloway Nathaniel Director |
28,309 | $0 | 28,309 (Direct) |
View |
2025-04-04 Option Award |
2025-04-07 9:41 pm |
N/A 2035-04-03 |
Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director |
27,647 | $0 | 27,647 (Direct) |
View |
2024-12-09 Option Award |
2024-12-10 09:00 am |
N/A 2034-12-08 |
Anebulo Pharmaceuticals Inc. | ANEB | Cunningham Richard Anthony Chief Executive Officer |
254,433 | $0 | 254,433 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director |
44,149 | $0 | 44,149 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | Calloway Nathaniel Director |
43,322 | $0 | 43,322 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director |
42,991 | $0 | 42,991 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director |
48,285 | $0 | 48,285 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. Director 10% Owner |
42,991 | $0 | 42,991 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | SHAH BIMAL R. Director |
44,976 | $0 | 44,976 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 4:23 pm |
N/A 2034-06-12 |
Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director |
44,149 | $0 | 44,149 (Direct) |
View |
2024-02-29 Option Award(A) |
2024-03-08 08:07 am |
N/A 2034-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer |
72,613 | $0 | 72,613 (Direct) |
View |
2024-02-29 Option Award |
2024-03-01 6:24 pm |
N/A 2034-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer |
72,613 | $0 | 72,613 (Direct) |
View |
2023-11-13 Option Award |
2023-12-20 4:22 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP 22NW Fund LP Director 10% Owner |
300,000 | $0 | 10,020,818 (Indirect) |
View |
2023-12-18 Gift |
2023-12-20 4:22 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP 22NW Fund LP Director 10% Owner |
300,000 | $0 | 10,020,818 (Indirect) |
View |
2023-10-06 Option Award |
2023-10-11 5:25 pm |
N/A 2033-10-05 |
Anebulo Pharmaceuticals Inc. | ANEB | Cunningham Richard Anthony Chief Executive Officer |
600,000 | $0 | 600,000 (Direct) |
View |
2023-10-06 Option Award |
2023-10-10 9:49 pm |
N/A 2033-10-05 |
Anebulo Pharmaceuticals Inc. | ANEB | SHAH BIMAL R. Director |
26,097 | $0 | 26,097 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 9:19 pm |
N/A 2032-12-08 |
Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer |
35,017 | $0 | 35,017 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 9:18 pm |
N/A 2032-12-08 |
Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer |
70,246 | $0 | 70,246 (Direct) |
View |
2022-11-01 Option Award |
2022-11-02 4:31 pm |
N/A 2027-10-31 |
Anebulo Pharmaceuticals Inc. | ANEB | Calloway Nathaniel Director |
59,149 | $0 | 59,149 (Direct) |
View |
2022-04-21 Option Award |
2022-10-04 4:13 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director 10% Owner |
30,425 | $0 | 12,030,425 (Direct) |
View |
2022-04-21 Option Award |
2022-10-04 4:11 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director |
30,425 | $0 | 30,425 (Direct) |
View |
2022-04-21 Option Award |
2022-10-03 7:56 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director |
30,425 | $0 | 30,425 (Direct) |
View |
2022-04-21 Option Award |
2022-10-03 7:53 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director |
30,425 | $0 | 30,425 (Direct) |
View |
2022-04-21 Option Award |
2022-10-03 7:51 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director |
30,425 | $0 | 30,425 (Direct) |
View |
2022-06-27 Option Award |
2022-10-03 7:48 pm |
N/A 2027-07-31 |
Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer |
77,457 | $0 | 77,457 (Direct) |
View |
2022-04-21 Option Award |
2022-09-30 9:36 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner |
30,425 | $0 | 11,454,820 (Direct) |
View |
2022-09-28 Option Award |
2022-09-30 9:36 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner |
1,703,577 | $2.81 | 11,454,820 (Indirect) |
View |
2022-09-28 Option Award |
2022-09-30 9:36 pm |
2022-09-28 2027-09-28 |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP Director 10% Owner |
1,703,577 | $0.125 | 11,454,820 (Direct) |
View |
2022-06-01 Option Award |
2022-06-07 4:10 pm |
2022-07-01 2027-06-30 |
Anebulo Pharmaceuticals Inc. | ANEB | Cundy Kenneth C Chief Scientific Officer |
350,169 | $0 | 350,169 (Direct) |
View |